Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 2, 2026 00:30 UTC |
Jin DavidChief Financial Officer
|
GrantCommon Stock, par value $0.001 | 1,190 | $1.82 | $2,164.61 |
DisclosureSEC source: 0001930732-26-000006 · form4-10012026_041005.xml · nonDerivative · entry 1 Jin David · CIK 0001930732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,652,761 F1 · shares: The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). F2 · balance_after: Total holdings include 1,230,000 shares underlying deferred restricted stock units and 400,000 shares underlying restricted stock units. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:50 UTC |
Jin DavidChief Financial Officer
|
GrantCommon Stock, par value $0.001 | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001930732-26-000003 · form4-06252026_010600.xml · nonDerivative · entry 1 Jin David · CIK 0001930732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,651,571 F1 · shares: Represents an award of 400,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in four equal annual installments, with the first installment vesting on January 5, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Vested restricted stock units will be settled in shares of the Issuer's common stock. F2 · balance_after: Total holdings include 1,230,000 shares underlying previously granted deferred restricted stock units. Read SEC document |
| April 01, 2026 Filed Apr 1, 2026 20:05 UTC |
Jin DavidChief Financial Officer
|
GrantCommon Stock, par value $0.001 | 2,967 | $2.18 | $6,456.19 |
DisclosureSEC source: 0001930732-26-000002 · form4-04012026_040401.xml · nonDerivative · entry 1 Jin David · CIK 0001930732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,251,571 F1 · shares: The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). F2 · balance_after: Total holdings include 1,230,000 shares underlying deferred restricted stock units. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 20:05 UTC |
ROSENWALD LINDSAY A MDDirector · PRESIDENT, CEO & CHAIRMAN · 10% owner
|
GrantCommon stock, par value $0.001 | 475,424 | $0.00 | $0.00 |
DisclosureSEC source: 0000941841-26-000002 · form4-03202026_040304.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · PRESIDENT, CEO & CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,586,841 F1 · shares: The Reporting Person was granted 475,424 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on March 18, 2026. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 16:05 UTC |
WEISS MICHAEL SDirector · Executive Vice Chairman
|
Grantcommon stock, par value $0.001 | 475,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001038977-26-000002 · form4-03202026_040301.xml · nonDerivative · entry 1 WEISS MICHAEL S · CIK 0001038977 · Director · Executive Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,276,562 F1 · shares: The Reporting Person was granted 475,424 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on March 18, 2026. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 16:30 UTC |
LOBELL J JAYDirector
|
Grantcommon stock, par value $0.001 | 27,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001172659-26-000002 · form4-01052026_040120.xml · nonDerivative · entry 1 LOBELL J JAY · CIK 0001172659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,397 F1 · shares: The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F2 · balance_after: Total holdings include 76,705 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 16:30 UTC |
Klein DovDirector
|
Grantcommon stock, par value $0.001 | 27,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001647971-26-000002 · form4-01052026_040119.xml · nonDerivative · entry 1 Klein Dov · CIK 0001647971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,105 F1 · shares: The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F2 · balance_after: Total holdings include 102,668 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 21:30 UTC |
Harvey JimmieDirector
|
Grantcommon stock, par value $0.001 | 27,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001529687-26-000002 · form4-01052026_040117.xml · nonDerivative · entry 1 Harvey Jimmie · CIK 0001529687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,704 F1 · shares: The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person on the January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the issuer. F2 · balance_after: Total holdings include 143,365 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 21:30 UTC |
Lorenz KevinDirector
|
Grantcommon stock, par value $0.001 | 27,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001772558-26-000002 · form4-01052026_040115.xml · nonDerivative · entry 1 Lorenz Kevin · CIK 0001772558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,009 F1 · shares: The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 21:30 UTC |
Hoenlein MalcolmDirector
|
GrantCommon Stock, par value $0.001 | 27,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001294517-26-000002 · form4-01052026_040113.xml · nonDerivative · entry 1 Hoenlein Malcolm · CIK 0001294517 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,747 F1 · shares: The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service. The Reporting Person elected to defer 25% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F2 · balance_after: Total holdings include 52,507 shares underlying deferred restricted stock units. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:30 UTC |
Jin DavidChief Financial Officer
|
GrantCommon Stock, par value $0.001 | 2,711 | $1.31 | $3,548.70 |
DisclosureSEC source: 0001930732-25-000004 · form4-10022025_041001.xml · nonDerivative · entry 1 Jin David · CIK 0001930732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,248,604 F1 · shares: The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). F2 · balance_after: Total holdings include 1,230,000 shares underlying deferred restricted stock units. Read SEC document |
| April 01, 2025 Filed Apr 1, 2025 20:20 UTC |
Jin DavidChief Financial Officer
|
GrantCommon Stock, par value $0.001 | 5,000 | $1.22 | $6,077.50 |
DisclosureSEC source: 0001415889-25-009369 · form4-04012025_080413.xml · nonDerivative · entry 1 Jin David · CIK 0001930732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,245,893 F1 · shares: The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). F2 · balance_after: Total holdings include 1,230,000 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:15 UTC |
ROSENWALD LINDSAY A MDDirector · PRESIDENT, CEO & CHAIRMAN · 10% owner
|
GrantCommon stock, par value $0.001 | 454,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000400 · form4-01032025_040103.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · PRESIDENT, CEO & CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,111,417 F1 · shares: The Reporting Person was granted 454,153 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2025. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 16:15 UTC |
WEISS MICHAEL SDirector · Executive Vice Chairman
|
Grantcommon stock, par value $0.001 | 454,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000402 · form4-01032025_040105.xml · nonDerivative · entry 1 WEISS MICHAEL S · CIK 0001038977 · Director · Executive Vice Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,801,138 F1 · shares: The Reporting Person was granted 454,153 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2025. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 16:28 UTC |
LOBELL J JAYDirector
|
Grantcommon stock, par value $0.001 | 49,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000444 · form4-01032025_090127.xml · nonDerivative · entry 1 LOBELL J JAY · CIK 0001172659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,075 F1 · shares: The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F2 · balance_after: Total holdings include 49,383 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 16:20 UTC |
Klein DovDirector
|
Grantcommon stock, par value $0.001 | 49,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000429 · form4-01032025_040109.xml · nonDerivative · entry 1 Klein Dov · CIK 0001647971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,783 F1 · shares: The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service. The reporting person elected to defer 50% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F2 · balance_after: Total holdings include 75,346 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:20 UTC |
Lu LucyDirector
|
Grantcommon stock, par value $0.001 | 49,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000428 · form4-01032025_040107.xml · nonDerivative · entry 1 Lu Lucy · CIK 0001542419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,273 F1 · shares: The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F2 · balance_after: Total holdings include 58,047 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:20 UTC |
Harvey JimmieDirector
|
Grantcommon stock, par value $0.001 | 49,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000427 · form4-01032025_040105.xml · nonDerivative · entry 1 Harvey Jimmie · CIK 0001529687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,382 F1 · shares: The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person on the January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the issuer. F2 · balance_after: Total holdings include 116,043 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:20 UTC |
Hoenlein MalcolmDirector
|
GrantCommon Stock, par value $0.001 | 49,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000425 · form4-01032025_040101.xml · nonDerivative · entry 1 Hoenlein Malcolm · CIK 0001294517 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,425 F1 · shares: The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service. The reporting person elected to defer 25% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F2 · balance_after: Total holdings include 45,676 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:20 UTC |
Lorenz KevinDirector
|
Grantcommon stock, par value $0.001 | 49,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000426 · form4-01032025_040103.xml · nonDerivative · entry 1 Lorenz Kevin · CIK 0001772558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,687 F1 · shares: The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 21:30 UTC |
Jin DavidChief Financial Officer
|
GrantCommon Stock, par value $0.001 | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-030071 · form4-12232024_041201.xml · nonDerivative · entry 1 Jin David · CIK 0001930732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,240,893 F1 · shares: Represents an award of 1,000,000 restricted stock units which will vest in 16 equal quarterly installments beginning after December 20, 2024. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and the consummation of a Corporate Transaction (as defined in the Fortress Biotech, Inc. 2013 Stock Incentive Plan); the amount will be distributed in the form of the Issuer's common stock. F2 · balance_after: Total holdings include 1,230,000 shares underlying deferred restricted stock units. Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:15 UTC |
Jin DavidChief Financial Officer
|
GrantCommon Stock, par value $0.001 | 2,625 | $1.23 | $3,224.29 |
DisclosureSEC source: 0001415889-24-024183 · form4-10012024_041004.xml · nonDerivative · entry 1 Jin David · CIK 0001930732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,893 F1 · shares: The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). F2 · balance_after: Total holdings include 230,000 shares underlying deferred restricted stock units. Read SEC document |
| September 23, 2024 Filed Sep 25, 2024 20:45 UTC |
ROSENWALD LINDSAY A MDDirector · PRESIDENT, CEO & CHAIRMAN · 10% owner
|
PurchaseWarrants to Purchase Common Stock · Derivative | 763,359 | $0.13 Strike: $1.84 | $95,419.88 |
DisclosureSEC source: 0001415889-24-023957 · form4-09252024_040901.xml · derivative · entry 2 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · PRESIDENT, CEO & CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 763,359 Underlying: Common Stock · 763,359 shares Expires 2030-03-23 Read SEC document |
| September 23, 2024 Filed Sep 25, 2024 20:45 UTC |
ROSENWALD LINDSAY A MDDirector · PRESIDENT, CEO & CHAIRMAN · 10% owner
|
PurchaseCommon stock, par value $0.001 | 763,359 | $1.84 | $1,404,580.56 |
DisclosureSEC source: 0001415889-24-023957 · form4-09252024_040901.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · PRESIDENT, CEO & CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,657,264 Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 20:05 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
PurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 5,000 | $7.48 | $37,417.50 |
DisclosureSEC source: 0001104659-24-079855 · tm2419471-1_4seq1.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,500 F1 · price: Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 11, 2024 was $7.35 to $7.49. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 10, 2024 Filed Jul 12, 2024 12:42 UTC |
Jin DavidChief Financial Officer
|
PurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 500 | $7.50 | $3,750.00 |
DisclosureSEC source: 0001104659-24-079409 · tm2419335-1_4seq1.xml · nonDerivative · entry 1 Jin David · CIK 0001930732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500 Read SEC document |
| July 09, 2024 Filed Jul 11, 2024 12:00 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
PurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 5,000 | $7.39 | $36,971.00 |
DisclosureSEC source: 0001104659-24-079100 · tm2419219-1_4seq1.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,500 F1 · price: Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 9, 2024 was $7.25 to $7.48. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 12:30 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
PurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 5,000 | $7.35 | $36,764.50 |
DisclosureSEC source: 0001104659-24-078786 · tm2419164-1_4seq1.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,500 F1 · price: Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 8, 2024 was $7.29 to $7.47. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 12:40 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
PurchaseCOMMON STOCK, PAR VALUE $0.001 | 20,000 | $1.64 | $32,724.00 |
DisclosureSEC source: 0001104659-24-076591 · tm2418613-1_4seq1.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,893,905 Read SEC document |
| May 20, 2024 Filed May 20, 2024 16:56 UTC |
Klein DovDirector
|
SaleCOMMON STOCK, PAR VALUE $0.001 | 10,000 | $1.89 | $18,900.00 |
DisclosureSEC source: 0001104659-24-063451 · tm2415000-1_4seq1.xml · nonDerivative · entry 1 Klein Dov · CIK 0001647971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,400 F1 · balance_after: Total holdings include 50,655 shares underlying deferred restricted stock and restricted stock units. Read SEC document |
| May 16, 2024 Filed May 20, 2024 21:00 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
PurchaseCOMMON STOCK, PAR VALUE $0.001 | 10,000 | $1.76 | $17,589.00 |
DisclosureSEC source: 0001104659-24-063455 · tm2415000-2_4seq1.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,873,905 Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:06 UTC |
Jin DavidChief Financial Officer
|
GrantCOMMON STOCK, PAR VALUE $0.001 | 2,352 | $1.70 | $3,998.40 |
DisclosureSEC source: 0001104659-24-042504 · tm2410608-1_4seq1.xml · nonDerivative · entry 1 Jin David · CIK 0001930732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,268 F1 · shares: The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). F2 · balance_after: Total holdings include 230,000 shares underlying deferred restricted stock units. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 13:15 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
PurchaseCOMMON STOCK, PAR VALUE $0.001 | 50,000 | $2.38 | $118,770.00 |
DisclosureSEC source: 0001104659-24-002464 · tm242385-1_4seq1.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,863,905 Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:46 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
GrantCOMMON STOCK, PAR VALUE $0.001 | 216,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-000898 · tm241755-10_4seq1.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,813,905 F1 · shares: The Reporting Person was granted 216,465 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2024. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 16:48 UTC |
WEISS MICHAEL SDirector · See Remarks · 10% owner
|
GrantCOMMON STOCK, PAR VALUE $0.001 | 216,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-000900 · tm241755-12_4seq1.xml · nonDerivative · entry 1 WEISS MICHAEL S · CIK 0001038977 · Director · See Remarks · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,346,985 F1 · shares: The Reporting Person was granted 216,465 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2024. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 16:52 UTC |
LOBELL J JAYDirector
|
GrantCOMMON STOCK, PAR VALUE $0.001 | 6,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-000912 · tm241755-7_4seq1.xml · nonDerivative · entry 1 LOBELL J JAY · CIK 0001172659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,692 F1 · shares: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. F2 · shares: One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 16:51 UTC |
Klein DovDirector
|
GrantCOMMON STOCK, PAR VALUE $0.001 | 6,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-000908 · tm241755-6_4seq1.xml · nonDerivative · entry 1 Klein Dov · CIK 0001647971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,400 F1 · shares: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. F2 · shares: One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. The reporting person elected to defer 5,332 of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F3 · balance_after: Total holdings include 50,655 shares underlying deferred restricted stock and restricted stock units. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:55 UTC |
Lu LucyDirector
|
GrantCOMMON STOCK, PAR VALUE $0.001 | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-000915 · tm241755-9_4seq1.xml · nonDerivative · entry 1 Lu Lucy · CIK 0001542419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,890 F1 · shares: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. F2 · shares: One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F3 · balance_after: Total holdings include 8,664 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:54 UTC |
Lorenz KevinDirector
|
GrantCOMMON STOCK, PAR VALUE $0.001 | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-000913 · tm241755-8_4seq1.xml · nonDerivative · entry 1 Lorenz Kevin · CIK 0001772558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,304 F1 · shares: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. F2 · shares: One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:50 UTC |
Hoenlein MalcolmDirector
|
GrantCOMMON STOCK, PAR VALUE $0.001 | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-000905 · tm241755-5_4seq1.xml · nonDerivative · entry 1 Hoenlein Malcolm · CIK 0001294517 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,042 F1 · shares: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. F2 · shares: One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F3 · balance_after: Total holdings include 33,330 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:49 UTC |
Harvey JimmieDirector
|
GrantCOMMON STOCK, PAR VALUE $0.001 | 6,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-000901 · tm241755-4_4seq1.xml · nonDerivative · entry 1 Harvey Jimmie · CIK 0001529687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,999 F1 · shares: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. F2 · shares: One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F3 · balance_after: Total holdings include 66,660 shares underlying deferred restricted stock units. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:47 UTC |
Rowinsky Eric KDirector
|
GrantCOMMON STOCK, PAR VALUE $0.001 | 6,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-000899 · tm241755-11_4seq1.xml · nonDerivative · entry 1 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,797 F1 · shares: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. F2 · shares: One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer. F3 · balance_after: Total holdings include 19,998 shares underlying deferred restricted stock units. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 21:05 UTC |
Jin DavidChief Financial Officer
|
GrantCOMMON STOCK, PAR VALUE $0.001 | 140,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-128788 · tm2333573-1_4seq1.xml · nonDerivative · entry 1 Jin David · CIK 0001930732 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,916 F1 · shares: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. F2 · shares: Represents an award of 140,000 restricted stock units which will vest in 16 equal quarterly installments after the grant date, December 20, 2023. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and the consummation of a Corporate Transaction (as defined in the Fortress Biotech, Inc. 2013 Stock Incentive Plan); the amount will be distributed in the form of the Issuer's common stock. F3 · balance_after: Total holdings include 230,000 shares underlying deferred restricted stock units. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 22:50 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
PurchaseWarrants to purchase Common Stock · Derivative | 1,567,515 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001104659-23-119188 · tm2330934-2_4seq1.xml · derivative · entry 2 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,567,515 Underlying: Common Stock · 1,567,515 shares Expires 2028-11-14 F2 · price: The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 22:50 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
PurchaseCOMMON STOCK, PAR VALUE $0.001 | 1,567,515 | $1.70 | $2,664,775.50 |
DisclosureSEC source: 0001104659-23-119188 · tm2330934-2_4seq1.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,597,440 F1 · shares: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. F2 · price: The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70. F1 · balance_after: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 17:46 UTC |
WEISS MICHAEL SDirector · See Remarks
|
PurchaseWarrants to purchase Common Stock · Derivative | 147,058 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001104659-23-119186 · tm2330934-1_4seq1.xml · derivative · entry 2 WEISS MICHAEL S · CIK 0001038977 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,058 Underlying: Common Stock · 147,058 shares Expires 2028-11-14 F2 · price: The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 17:46 UTC |
WEISS MICHAEL SDirector · See Remarks
|
PurchaseCOMMON STOCK, PAR VALUE $0.001 | 147,058 | $1.70 | $249,998.60 |
DisclosureSEC source: 0001104659-23-119186 · tm2330934-1_4seq1.xml · nonDerivative · entry 1 WEISS MICHAEL S · CIK 0001038977 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,130,520 F1 · shares: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. F2 · price: The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70. F1 · balance_after: Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. Read SEC document |
| September 26, 2023 Filed Sep 27, 2023 12:20 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
PurchaseCOMMON STOCK, PAR VALUE $0.001 | 100,000 | $0.28 | $28,330.00 |
DisclosureSEC source: 0001104659-23-104099 · tm2327003-1_4.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,449,091 Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 12:30 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
PurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 10,000 | $9.34 | $93,400.00 |
DisclosureSEC source: 0001104659-23-093700 · tm2324200-1_4seq1.xml · nonDerivative · entry 2 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,500 Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 12:30 UTC |
ROSENWALD LINDSAY A MDDirector · President, CEO & Chairman · 10% owner
|
PurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 10,000 | $11.75 | $117,500.00 |
DisclosureSEC source: 0001104659-23-093700 · tm2324200-1_4seq1.xml · nonDerivative · entry 1 ROSENWALD LINDSAY A MD · CIK 0000941841 · Director · President, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.